Rhythm Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US76243J1051

SecurityRYTM / Rhythm Pharmaceuticals, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership18,147 shares
Latest Disclosed Value $ 1,578,245
Captrust Financial Advisors reports 0.97% decrease in ownership of RYTM / Rhythm Pharmaceuticals, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 18,147 shares of Rhythm Pharmaceuticals, Inc. (US:RYTM) valued at $1,578,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 18,325 shares of Rhythm Pharmaceuticals, Inc.. This represents a change in shares of -0.97% during the quarter. The current value of the position is $1,589,859 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RHYTHM PHARMACEUTICALS INC COM Stock 76243J105 18,147 -178 -0.97 1,578 -19.53 0.0027
2026-02-17 2025-12-31 13F RHYTHM PHARMACEUTICALS INC COM Stock 76243J105 18,325 67 0.37 1,962 6.40 0.0037
2025-11-19 2025-09-30 13F RHYTHM PHARMACEUTICALS INC COM Stock 76243J105 18,258 787 4.50 1,844 67.09 0.0038
2025-08-15 2025-06-30 13F RHYTHM PHARMACEUTICALS INC COM Stock 76243J105 17,471 114 0.66 1,104 20.02 0.0025
2025-05-15 2025-03-31 13F RHYTHM PHARMACEUTICALS INC COM Stock 76243J105 17,357 17,357 919 0.0023
2022-02-12 2021-12-31 13F RHYTHM PHARMACEUTICALS INC COM Common Stock 76243J105 0 -19 -100.00 0 0.0000
2021-11-16 2021-09-30 13F RHYTHM PHARMACEUTICALS INC COM Common Stock 76243J105 19 -12 -38.71 0 -100.00
2021-08-16 2021-06-30 13F RHYTHM PHARMACEUTICALS INC COM Common Stock 76243J105 31 0 0.00 1 0.00 0.0000
2021-05-17 2021-03-31 13F RHYTHM PHARMACEUTICALS INC COM Common Stock 76243J105 31 31 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.